Imugene Limited

Imugene (ASX:IMU) is an immuno-oncology focused biopharmaceutical company developing HER-2+ gastric and breast cancer immunotherapies. Our mission is to build a pipeline of B-cell peptide cancer vaccines.

Latest Media Releases

Imugene Limited (ASX:IMU) - trading halt

28/11/2019 09:32:00

The securities of Imugene Limited ('IMU') will be placed in trading halt at the request of IMU, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain…

Latest News